The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Sema4
A systematic analysis of off-label drug use in real-world data (RWD) across more than 145,000 cancer patients.
 
Jonathan McCafferty
Employment - Sema4
 
Kartikey Grover
Employment - Icahn School of Medicine at Mount Sinai
 
Li Li
Employment - Sema4
 
Zhiqiang Li
Employment - Seachaid Pharma
 
Marc Y. Fink
Employment - Sema4
 
Howard Goldsweig
Employment - Sema4
 
Meng Ma
Employment - Sema4
 
Xiang Zhou
Employment - SEMA4
 
Tommy Mullaney
Employment - Sema4
 
Arielle Redfern
Employment - Sema4
 
Whitney Jappe
Employment - Sema4
Stock and Other Ownership Interests - COTA
 
Michelle Zimmerman
No Relationships to Disclose
 
Tony Prentice
Employment - Sema4
 
Qi Pan
Employment - Boehringer Ingelheim; GenScript; Sema4
Leadership - Boehringer Ingelheim; GenScript; Sema4
Stock and Other Ownership Interests - GenScript; Sema4
Consulting or Advisory Role - Adlai Nortye; Simcere
Patents, Royalties, Other Intellectual Property - Boehringer Ingelheim; GenScript
Travel, Accommodations, Expenses - Sema4
 
William K. Oh
Leadership - checkpoint Sciences
Stock and Other Ownership Interests - Bellicum Pharmaceuticals
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; checkpoint Sciences; Churchill Pharmaceuticals; Dendreon; Inovio Pharmaceuticals; Janssen; Sanofi; Sema4; TYME
Research Funding - Sotio (Inst)
 
Eric Schadt
Employment - Sema4
 
Dan Li
Employment - Pacira Pharmaceuticals (I); Sema4; Symphogen (I)
Stock and Other Ownership Interests - Sema4
 
Rong Chen
Employment - Sema4; Sema4 (I)
Stock and Other Ownership Interests - Personalis; Sema4
Consulting or Advisory Role - Roche
Research Funding - Boehringer Ingelheim
Patents, Royalties, Other Intellectual Property - Quest Diagnosis, Personalis
Travel, Accommodations, Expenses - Roche